270 related articles for article (PubMed ID: 7822107)
1. Comparative conformational analyses of mu-selective dermorphin and delta-selective deltorphin-II in aqueous solution by 1H-NMR spectroscopy.
Segawa M; Ohno Y; Doi M; Inoue M; Ishida T; Iwashita T
Int J Pept Protein Res; 1994 Sep; 44(3):295-304. PubMed ID: 7822107
[TBL] [Abstract][Full Text] [Related]
2. Solution conformation of mu-selective dermorphin and delta-selective deltorphin-I in phospholipid micelles, studied by NMR spectroscopy and molecular dynamics simulations.
Segawa M; Ohno Y; Doi M; Ishida T; Iwashita T
Int J Pept Protein Res; 1995 Jul; 46(1):37-46. PubMed ID: 7558595
[TBL] [Abstract][Full Text] [Related]
3. Conformation of deltorphin-II in membrane environment studied by two-dimensional NMR spectroscopy and molecular dynamics calculations.
Ohno Y; Segawa M; Ohishi H; Doi M; Kitamura K; Ishida T; Inoue M; Iwashita T
Eur J Biochem; 1993 Feb; 212(1):185-91. PubMed ID: 8383038
[TBL] [Abstract][Full Text] [Related]
4. New features of the delta opioid receptor: conformational properties of deltorphin I analogues.
Balboni G; Marastoni M; Picone D; Salvadori S; Tancredi T; Temussi PA; Tomatis R
Biochem Biophys Res Commun; 1990 Jun; 169(2):617-22. PubMed ID: 2162669
[TBL] [Abstract][Full Text] [Related]
5. Conformation-activity relationships of cyclo-constrained micro/delta opioid agonists derived from the N-terminal tetrapeptide segment of dermorphin/deltorphin.
Rodziewicz-Motowidło S; Czaplewski C; Luczak S; Ciarkowski J
J Pept Sci; 2008 Aug; 14(8):898-902. PubMed ID: 18338322
[TBL] [Abstract][Full Text] [Related]
6. Dermenkephalin and deltorphin I reveal similarities within ligand-binding domains of mu- and delta-opioid receptors and an additional address subsite on the delta-receptor.
Charpentier S; Sagan S; Delfour A; Nicolas P
Biochem Biophys Res Commun; 1991 Sep; 179(3):1161-8. PubMed ID: 1656944
[TBL] [Abstract][Full Text] [Related]
7. Substitution of aromatic and nonaromatic amino acids for the Phe3 residue in the delta-selective opioid peptide deltorphin I: effects on binding affinity and selectivity.
Heyl DL; Schmitter SJ; Bouzit H; Johnson TW; Hepp AM; Kurtz KR; Mousigian C
Int J Pept Protein Res; 1994 Nov; 44(5):420-6. PubMed ID: 7896499
[TBL] [Abstract][Full Text] [Related]
8. Folded conformations of the delta-selective opioid dermenkephalin with head-to-tail interactions. A simulated annealing study through NMR restraints.
Naim M; Nicolas P; Baron D
Int J Pept Protein Res; 1996 May; 47(5):353-60. PubMed ID: 8791158
[TBL] [Abstract][Full Text] [Related]
9. Examination of the conformational meaning of "delta-address" in the dermenkephalin sequence.
Nikiforovich GV; Hruby VJ
Biochem Biophys Res Commun; 1990 Dec; 173(2):521-7. PubMed ID: 1979733
[TBL] [Abstract][Full Text] [Related]
10. Conformational properties of deltorphin: new features of the delta-opioid receptor.
Temussi PA; Picone D; Tancredi T; Tomatis R; Salvadori S; Marastoni M; Balboni G
FEBS Lett; 1989 Apr; 247(2):283-8. PubMed ID: 2541018
[TBL] [Abstract][Full Text] [Related]
11. Bioactivity of new mu and delta opioid peptides.
Capasso A
Med Chem; 2007 Sep; 3(5):480-7. PubMed ID: 17897075
[TBL] [Abstract][Full Text] [Related]
12. Dermenkephalin (Tyr-D-Met-Phe-His-Leu-Met-Asp-NH2): a potent and fully specific agonist for the delta opioid receptor.
Amiche M; Sagan S; Mor A; Delfour A; Nicolas P
Mol Pharmacol; 1989 Jun; 35(6):774-9. PubMed ID: 2543911
[TBL] [Abstract][Full Text] [Related]
13. Solution conformations of deltorphin-I obtained from combined use of quantitative 2D-NMR and energy calculations: a comparison with dermenkephalin.
Naim M; Nicolas P; Benajiba A; Baron D
J Pept Res; 1998 Dec; 52(6):443-56. PubMed ID: 9924989
[TBL] [Abstract][Full Text] [Related]
14. Folding trends in a flexible peptide: two-dimensional NMR study of deltorphin-I, a delta selective opioid heptapeptide.
Duchesne D; Naim M; Nicolas P; Baron D
Biochem Biophys Res Commun; 1993 Sep; 195(2):630-6. PubMed ID: 8373402
[TBL] [Abstract][Full Text] [Related]
15. Characterisation and visualisation of [3H]dermorphin binding to mu opioid receptors in the rat brain. Combined high selectivity and affinity in a natural peptide agonist for the morphine (mu) receptor.
Amiche M; Sagan S; Mor A; Pelaprat D; Rostene W; Delfour A; Nicolas P
Eur J Biochem; 1990 May; 189(3):625-35. PubMed ID: 2161761
[TBL] [Abstract][Full Text] [Related]
16. Molecular dynamics conformations of deltorphin analogues advocate delta opioid binding site models.
Bryant SD; Attila M; Salvadori S; Guerrini R; Lazarus LH
Pept Res; 1994; 7(4):175-84. PubMed ID: 7696838
[TBL] [Abstract][Full Text] [Related]
17. The mu-selective heptapeptide opioid dermorphin has two conformations around Phe3 psi with no head-to-tail interaction. A quantitative 2-D NMR and molecular modeling analysis.
Riand J; Nicolas P; Baron D
J Biomol Struct Dyn; 2002 Dec; 20(3):359-73. PubMed ID: 12437374
[TBL] [Abstract][Full Text] [Related]
18. Conformational comparison of mu-selective endomorphin-2 with its C-terminal free acid in DMSO solution, by 1H NMR spectroscopy and molecular modeling calculation.
In Y; Minoura K; Ohishi H; Minakata H; Kamigauchi M; Sugiura M; Ishida T
J Pept Res; 2001 Nov; 58(5):399-412. PubMed ID: 11892849
[TBL] [Abstract][Full Text] [Related]
19. Conformational restriction of Tyr and Phe side chains in opioid peptides: information about preferred and bioactive side-chain topology.
Tourwé D; Verschueren K; Frycia A; Davis P; Porreca F; Hruby VJ; Toth G; Jaspers H; Verheyden P; Van Binst G
Biopolymers; 1996 Jan; 38(1):1-12. PubMed ID: 8679939
[TBL] [Abstract][Full Text] [Related]
20. pKa and volume of residue one influence delta/mu opioid binding: QSAR analysis of tyrosine replacement in a nonselective deltorphin analogue.
Heyl DL; Schullery SE; Renganathan K; Jayamaha MN; Rodgers DW; Traynor JR
Bioorg Med Chem; 2003 Aug; 11(17):3761-8. PubMed ID: 12901921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
